Skip to main content

The FDA Just Approved a First-Of-Its-Kind Drug That Targets Cancer’s Genes

  • Keytruda, a new immunotherapy drug used to treat solid cancers that display a particular biomarker, just received FDA approval.
  • Along with other cutting-edge cancer treatments, this represents a focus on genetics rather than location of the tumor in treatment and prevention.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2023 Esophageal Cancer Education Foundation- by domino